Elanco Animal Health Incorporated (ELAN)
After hours:
| Previous close | 13.52 |
| Open | 15.74 |
| Bid | 16.78 x 900 |
| Ask | 16.79 x 1400 |
| Day's range | 15.24 - 17.23 |
| 52-week range | 7.88 - 17.23 |
| Volume | |
| Avg. volume | 4,083,085 |
| Market cap | 8.345B |
| Beta (5Y monthly) | 1.30 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Elanco Animal Health Reports First Quarter 2024 Results
Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the first quarter of 2024, provided guidance for the second quarter of 2024, and updated guidance for the full year 2024.
- PR Newswire
Elanco's 'Parvo is Poop' Campaign Unleashes Awareness and Action on National Parvo Awareness Day
Elanco Animal Health Incorporated (NYSE: ELAN) today unleashed a multi-faceted educational campaign – declaring today as the first-ever National Parvo Awareness Day, aimed at bringing awareness to this devastating and often-fatal puppy disease. As part of this effort, Elanco is releasing Parvo is Poop – an eye-catching campaign highlighting the way the virus spreads, the symptoms and the breakthrough solution to treat canine parvovirus (parvo).
- PR Newswire
Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance.
